Watch Demo

Iceland Digestive System Disorder Industry Outlook 2022 - 2026

See how Iceland Digestive System Disorder performed compared to key markets such as Germany, Japan and South Korea.

Key Market Indicators

Sales of digestive system disorder medicine in Iceland are expected to reach $30 million by 2026. The country recorded $26 million in sales in 2021, representing a 1.9% annual growth rate since 1985. Iceland currently ranks 28th in the world in terms of digestive system disorder medicine sales, with Luxembourg in the lead at $26 million. Japan, South Korea, and Canada ranked 2nd, 3rd and 4th, respectively.

Marketing Banner

Iceland Digestive System Disorder Market Data and Forecasts

How much will Iceland Digestive System Disorder Market grow to 2026?

Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use in Iceland
Forecast: Alimentary Tract and Metabolism Medicine Sales in Iceland
Forecast: Alimentary Tract and Metabolism Medicine Sales in Iceland
Forecast: Alimentary Tract and Metabolism Medicine Sales in Iceland
More in Digestive System Disorder Industry for 2028